http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102005027956-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a920c2d2edcb53f1f0b3c618f105755d |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5254 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5252 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-24064 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00 |
| filingDate | 2005-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5bfd13c80c539345f2a77c51f629e1bf |
| publicationDate | 2006-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | DE-102005027956-A1 |
| titleOfInvention | Highly attenuated poxvirus strains, processes for their preparation and their use as paramunity inducers or for the production of vector vaccines |
| abstract | ThenThe present invention relates to highly attenuated animal pox virus strains andntheir use as paramunity inducersnor for the preparation of vector vaccines. The animal pox strains according to the invention havenby the method of Hochattenuierung no virulent andnimmunizing properties more. The invention further relatesnProcess for the preparation of such highly attenuated poxvirus strains andntheir use for inducing paramunity, d. H. to activate thennon-specific immune system in mammalsnand humans or for the production of vector vaccines for the specificnImmunization with the positive side effect of paramunization.nThe highly attenuated inventionnAnimal poxviruses are thus suitable for prevention and treatmentnof immunodeficiency-associatednDiseases. Preferred embodimentsnconcern highly attenuated Orthopox (eg camelpox viruses), Leporipoxn(eg myxomaviruses), avipox, parapox and other orthopoxvirus strains, such asnz. B. MVA, which have excellent paramunizing propertiesnand where the immunizing properties have been lostnare. |
| priorityDate | 2005-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 209.